NIH-funded research NIH-funded research

SEC-MALS instrument for studying biomolecules and nanoparticles

Official title: Acquisition of SEC-MALS for Investigations in Molecular Assembly and Characterization of Polymeric Macromolecules, Nanoparticles, and Bioassemblies

Funded at University of Texas Tyler · NIH-11366110 · Data updated 2026-11-12

A new SEC-MALS instrument will help scientists measure the size, weight, and heterogeneity of biomolecules and nanoparticles to advance biomedical research and student training.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Tyler
NIH-funded
Lab location1 site (Tyler, United States)
Project startJuly 1, 2026
Project endJune 30, 2027
Funding year2026
Award (this year)$250,000
NIH project number1S10GM164881-01
Project IDNIH-11366110 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable for this instrument grant; this is a core facility instrument that will support research across departments and training programs.

Less likely to help

Patients may not directly participate, as this is a shared instrumentation grant.

What this research studies

This grant funds the purchase of a SEC-MALS instrument (Wyatt DAWN 8 MALS with SEC) to characterize biomolecules, polymers, and nanoparticles. It will be housed at the University of Texas Tyler and used across Chemistry, Biology, Pharmacy, and the School of Medicine, with a focus on biomedical research and education. The device will enable in-house measurements of molar mass, hydrodynamic radius, aggregation state, and sample heterogeneity, reducing the need for external facilities. It will also enhance undergraduate training in biochemistry, organic, and polymer chemistry labs, supporting career pathways in medicine and health fields. The long-term goal is to expand research and education capacity regionally by providing broader access to advanced characterization tools.

Why it matters

Potential benefit: If successful, patients could benefit indirectly through faster biomedical discoveries and better-trained clinicians and researchers.

How similar studies have gone: Other institutions have shown that SEC-MALS enhances characterizations and speeds up discovery when integrated into research programs.

Where this research is happening

  • University of Texas Tyler
    Tyler, United States
    Active

Researchers

  • Principal investigator: Patterson, Dustin Patrick — University of Texas Tyler
  • Study coordinator: Patterson, Dustin Patrick

Related research

Other NIH-funded projects on the same topics.

  • Using natural killer cell-derived vesicles for targeted cancer imaging and treatment

    This study is exploring how to use special immune cells called natural killer (NK) cells to create tiny delivery vehicles that can send cancer treatments right to tumors, which could lead to better results and fewer side effects for patients.

    NIH research University of Texas Tyler · Tyler, United States · NIH-11095375

  • Investigating new compounds to protect brain cells in Parkinson's disease using zebrafish models

    This study is looking for new medications that could help protect brain cells in people with Parkinson's disease by testing a special compound in zebrafish to see if it can keep important brain cells healthy and slow down the disease.

    NIH research University of Texas Tyler · Tyler, United States · NIH-11082980

  • Improving ultrasound imaging speed and accuracy using new mathematical methods

    This study is working on new technology to make ultrasound images clearer and faster, which could help doctors better monitor how well your organs are working and improve treatments, so you get more accurate results when you need an ultrasound.

    NIH research University of Texas Tyler · Tyler, United States · NIH-10974659

  • New treatment targeting HER2 in breast cancer

    This study is testing a new treatment that could help people with certain types of breast cancer by blocking a protein called HER2, which helps cancer cells grow, and it aims to be safer and more effective than current options.

    NIH research University of Texas Tyler · Tyler, United States · NIH-10884074

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.